News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Corcept Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Beach
The Day In Review: InterMune, Inc. Retrenches
March 20, 2007
·
1 min read
Biotech Beach
The Day In Review: Amgen Buys Avidia, Inc. For $290 Million
October 3, 2006
·
1 min read
BioCapital
The Week In Review: A Late Summer Bounce For Biotech
September 5, 2006
·
1 min read
Biotech Beach
The Day In Review: Immunicon Corporation Rises On AstraZeneca PLC Deal
August 7, 2006
·
1 min read
Biotech 2005: New Drugs Hold The Key
October 19, 2005
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session
March 30, 2026
·
4 min read
Press Releases
Onco360® Has Been Selected as the National Pharmacy Partner for LIFYORLI™ (relacorilant)
March 27, 2026
·
2 min read
Press Releases
FDA Approves Corcept’s Selective Glucocorticoid Receptor Antagonist Lifyorli™ (relacorilant) Plus Nab-Paclitaxel for Treatment of Patients with Platinum-Resistant Ovarian Cancer
March 26, 2026
·
14 min read
Press Releases
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2025 Audited Financial Results, Provides Corporate Update
February 25, 2026
·
13 min read
Press Releases
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results, Provide Corporate Update and Host Conference Call
February 18, 2026
·
1 min read
Press Releases
Overall Survival Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
January 23, 2026
·
7 min read
Press Releases
Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism
January 1, 2026
·
3 min read
Press Releases
Corcept Therapeutics Announces Third Quarter Financial Results, Oncology Development Programs and Provides Corporate Update
November 4, 2025
·
14 min read
Press Releases
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
October 28, 2025
·
1 min read
Press Releases
Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment
October 19, 2025
·
7 min read
